These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 14715181)
21. Implantable defibrillators in the third millennium: increasingly relegated to a standby role? Saksena S J Am Coll Cardiol; 2000 Sep; 36(3):828-31. PubMed ID: 10987606 [No Abstract] [Full Text] [Related]
22. Anti-arrhythmic effects of statins: a hypothesis remains to be tested. Guo HM Heart Rhythm; 2008 Apr; 5(4):511-2. PubMed ID: 18362017 [No Abstract] [Full Text] [Related]
23. The role of implantable cardioverter defibrillators in dilated cardiomyopathy. Borggrefe M; Chen X; Martinez-Rubio A; Hindricks G; Haverkamp W; Block M; Breithardt G Am Heart J; 1994 Apr; 127(4 Pt 2):1145-50. PubMed ID: 8160594 [TBL] [Abstract][Full Text] [Related]
24. [Implantable defibrillator--with focus on primary prevention. Detailed patient information about risks and benefits is required]. Jensen SM; Kesek M Lakartidningen; 2009 Nov 25-Dec 1; 106(48):3236, 3238-41. PubMed ID: 20101834 [No Abstract] [Full Text] [Related]
25. Late dofetilide-associated life-threatening proarrhythmia. Kolb C; Ndrepepa G; Zrenner B Int J Cardiol; 2008 Jul; 127(2):e54-6. PubMed ID: 17588691 [TBL] [Abstract][Full Text] [Related]
26. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study. Cappato R Am J Cardiol; 1999 Mar; 83(5B):68D-73D. PubMed ID: 10089843 [TBL] [Abstract][Full Text] [Related]
30. Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial. Robinson VM; Bharucha DB; Mahaffey KW; Dorian P; Kowey PR; Am Heart J; 2017 Mar; 185():43-51. PubMed ID: 28267474 [TBL] [Abstract][Full Text] [Related]
31. The effect of spironolactone on ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators. Zarraga IG; Dougherty CM; MacMurdy KS; Raitt MH Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):739-47. PubMed ID: 22773022 [TBL] [Abstract][Full Text] [Related]
32. Multiple inappropriate defibrillator discharges due to Twiddler's syndrome. Asbach S; Brunner M; Zehender M; Bode C; Faber TS Wien Klin Wochenschr; 2005 Dec; 117(23-24):801. PubMed ID: 16437315 [No Abstract] [Full Text] [Related]
33. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study. Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615 [TBL] [Abstract][Full Text] [Related]
34. Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. Hickey K; Curtis AB; Lancaster S; Larsen G; Warwick D; McAnulty J; Mitchell LB Am Heart J; 2001 Jul; 142(1):99-104. PubMed ID: 11431664 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426 [TBL] [Abstract][Full Text] [Related]